Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01107795 · ClinicalTrials.gov registry record

Prospective Study to Evaluate Outcomes From Transoral BOT Resection for OSAHS

A clinical trial, sponsored by University of Alabama at Birmingham.

Terminated
Registry status
41
Enrollment target

NCT01107795: Clinical Trial study, sponsored by University of Alabama at Birmingham.

NCT01107795 is a clinical trial that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01107795 was terminated before completion, sponsored by University of Alabama at Birmingham.

TERMINATED
Registry status
41 participants
Enrollment target

Study Summary

This is a prospective observational study that will collect outcome data for patients who choose to undergo transoral tongue base operations for Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)as part of their standard of care treatment. This is a data collection study only and does not provide for evaluations or treatment of OSAHS.

Primary Outcome

Improvement in Apnea Hypopnea Index (AHI) score, as measured by a polysomnogram sleep study. The AHI score is the number of apnea events per hour, with a lower score indicating mild sleep apnea and a higher score indicating severe sleep apnea. An improved AHI score would be a lower score at 6 months than at 3 months and baseline.

Interventions

  • PROCEDURE Transoral Robotic Surgery

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2010-03-04
Est. Completion 2019-07-26
University of Alabama at Birmingham

1,160 total trials

Why NCT01107795 stopped before completion

NCT01107795 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Transoral Robotic Surgery is the first listed.

NCT01107795 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01107795 about?

NCT01107795 is a clinical study titled "Prospective Study to Evaluate Outcomes From Transoral BOT Resection for OSAHS". This is a prospective observational study that will collect outcome data for patients who choose to undergo transoral tongue base operations for Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)as part of their standard of care treatment. This is a data collection study only and does not provide for...

What is the current status of trial NCT01107795?

This trial is currently terminated. The enrollment target is 41 participants. The study started on 2010-03-04. Estimated completion is 2019-07-26.

What interventions are being tested in trial NCT01107795?

The interventions under investigation include: Transoral Robotic Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT01107795?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01107795, the US trial registry maintained by the National Library of Medicine. NCT01107795 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.